Lumena Pharmaceuticals

One of Shire's top blockbuster drug prospects flops in a key PhII study
Fierce Biotech
Thu, 04/9/15 - 09:22 am
Shire
SHP625
Lumena Pharmaceuticals
Shire Acquisition Bolsters Its Rare, And Maybe Not-So-Rare, Disease Portfolio
Seeking Alpha
Mon, 05/19/14 - 09:23 am
Shire
M&A
liver disease
Lumena Pharmaceuticals
LUM001
LUM002
obesity
Shire buys Lumena Pharma for at least $260 million
Yahoo/Reuters
Mon, 05/12/14 - 08:10 am
Shire
Lumena Pharmaceuticals
M&A
Lumena swings for a $75M IPO to bear down on liver diseases
Fierce Biotech
Thu, 04/3/14 - 09:30 am
IPOs
Lumena Pharmaceuticals
LUM001
liver disease
Pulse of J.P. Morgan 2014: Interviews with 17 biopharma execs
Fierce Biotech
Fri, 01/17/14 - 05:54 pm
JPMHC 2014
Algeta
Macrogenics
Xencor
Acetylon
Enanta Pharmaceuticals
Clinigen
Iroko Pharmaceuticals
Protalix BioTherapeutics
Ambrx
Roche
Sialix
Verastem
pRED
Cubist Pharmaceuticals
Celgene
Otonomy
Lumena Pharmaceuticals